I agree that this site is using cookies. You can find further informations here.
X
Bašić-Kinda, Sandra
65  results:
Search for persons X
?
1

Treatment-Related Risk Factors for Adverse Outcomes of COVI..:

Aurer, Igor ; Jakšić, Ozren ; Bašić-Kinda, Sandra...
Biomedicines.  12 (2024)  2 - p. 331 , 2024
Link: https://doi.org/10.3390/..
 
?
2

Long-Term Results of IFRT vs. ISRT in Infradiaphragmal Fiel..:

Galunic Bilic, Lea ; Santek, Fedor ; Mitrovic, Zdravko...
Cancers.  16 (2024)  3 - p. 649 , 2024
Link: https://doi.org/10.3390/..
 
?
3

Reduced Corticosteroid Exposure Is Safe and Does Not Reduce..:

Hude Dragičević, Ida ; Bašić-Kinda, Sandra ; Markotić, Helena...
Medicina.  60 (2024)  3 - p. 430 , 2024
Link: https://doi.org/10.3390/..
 
?
4

Efficacy and toxicity of infradiaphragmal radiotherapy fiel..:

Galunic Bilic, Lea ; Santek, Fedor ; Grah, Josip J....
La radiologia medica.  128 (2023)  4 - p. 492-500 , 2023
Link: https://doi.org/10.1007/..
 
?
5

Glomerular filtration rate is an independent prognostic fac..:

Premužić, Vedran ; Bašić-Kinda, Sandra ; Radman, Ivo...
Medicine.  102 (2023)  20 - p. e33675 , 2023
Link: https://doi.org/10.1097/..
 
?
6

P-258 Carfilzomib in relapsed/refractory multiple myeloma p..:

Galušić, Davor ; Batinić, Josip ; Dreta, Barbara...
Clinical Lymphoma Myeloma and Leukemia.  23 (2023)  - p. S178 , 2023
Link: https://doi.org/10.1016/..
 
?
7

P-234 Daratumumab in relapsed/refractory multiple myeloma p..:

Batinić, Josip ; Dreta, Barbara ; Galušić, Davor...
Clinical Lymphoma Myeloma and Leukemia.  23 (2023)  - p. S164 , 2023
Link: https://doi.org/10.1016/..
 
?
8

Non-Myelofibrosis Chronic Myeloproliferative Neoplasm Patie..:

Sertić, Zrinka ; Lucijanić, Marko ; Bašić-Kinda, Sandra...
Biomedicines.  10 (2022)  11 - p. 2892 , 2022
Link: https://doi.org/10.3390/..
 
?
9

P016: Reduced steroid exposure is safe and does not reduce ..:

Dragičević, Ida Hude ; Bašić-Kinda, Sandra ; Dujmović, Dino...
HemaSphere.  6 (2022)  - p. 8-8 , 2022
Link: https://doi.org/10.1097/..
 
?
10

Efficacy and Safety of Obinutuzumab-chemotherapy Combinatio..:

Galusic, Davor ; Basic-Kinda, Sandra ; Pijuk, Andela...
HemaSphere.  6 (2022)  12 - p. e807 , 2022
Link: https://doi.org/10.1097/..
 
?
11

Bone Marrow Microenvironment Interplay and Current Clinical..:

Bila, Jelena ; Katodritou, Eirini ; Guenova, Margarita...
Journal of Clinical Medicine.  10 (2021)  17 - p. 3940 , 2021
Link: https://doi.org/10.3390/..
 
?
12

R-CHOEP14 in younger high-risk patients with large B cell l..:

Bašić-Kinda, Sandra ; Radman, Ivo ; Dujmović, Dino...
Annals of Hematology.  100 (2020)  6 - p. 1517-1524 , 2020
Link: https://doi.org/10.1007/..
 
?
13

Influence of Blood Count, Cardiovascular Risks, Inherited T..:

Horvat, Ivana ; Boban, Ana ; Zadro, Renata...
Clinical Lymphoma Myeloma and Leukemia.  19 (2019)  1 - p. 53-63 , 2019
Link: https://doi.org/10.1016/..
 
?
14

Serum chitotriosidase: a circulating biomarker in polycythe..:

Krecak, Ivan ; Gveric-Krecak, Velka ; Roncevic, Pavle...
Hematology.  23 (2018)  10 - p. 793-802 , 2018
Link: https://doi.org/10.1080/..
 
?
15

High-dose ifosfamide and mitoxantrone (HDIM) in patients wi..:

Aurer, Igor ; Nemet, Damir ; Mitrović, Zdravko...
Annals of Hematology.  95 (2016)  7 - p. 1129-1136 , 2016
Link: https://doi.org/10.1007/..
 
1-15